Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 11 Feb 2022 for Iradimed CORP, €846k. Read the official filing
Filing timeline
BuySaleChristopher K. Scott
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher K. Scott: trading record in brief
This profile gathers the share dealings of Christopher K. Scott in Iradimed Corp, where the filings describe the role as finance chief. Between 15 November 2021 and 11 February 2022, the trades on record add up to 5 filings.
The open-market record consists of 1 sale worth €846k, with no purchase. Outside the open market, there are 2 share grants and 2 option exercises. 2022 to date brings no purchases and 1 sale.
On 11 February 2022 came the latest disclosure, an open-market sale for €846k in Iradimed Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher K. Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
19,286 shares@ US$50.058377.1% of flowCommon StockSEC:0000898432-22-000100:0
1,575 sharesCommon StockSEC:0000898432-21-000770:0
2,952 sharesCommon StockSEC:0000898432-21-000756:0
26,715 shares@ US$9.8421.3% of flowCommon StockSEC:0000898432-21-000738:0
2,027 shares@ US$9.841.6% of flowCommon StockSEC:0000898432-21-000730:0
5 of 5 declarations
